Generic Erosion To Significantly Stunt The Growth Of The Bipolar Disorder Drug Market In The United States

Sales of Anticonvulsants, Antipsychotics, and Antidepressants Will Begin a Steady Decline After 2008, According to a New Study from Decision Resources

August 31, 2004–Waltham, Mass.--Decision Resources, Inc., one of the world’s leading research and advisory firms focusing on pharmaceutical and health care issues, forecasts that generic erosion will significantly stunt the growth of the bipolar disorder drug market in the United States. According to the new Pharmacor study entitled Bipolar Disorder, sales of anticonvulsants, antipsychotics, and antidepressants will begin a steady decline after 2008 as they lose patent protection.

< BACK